Chief Medical Officer

Benefits

Additional Information

The Company Dexcom Corporation (NASDAQ DXCM) is a pioneer and global leader in continuous glucose monitoring (CGM). Dexcom began as a small company with a big dream: To forever change how diabetes is managed. To unlock information and insights that drive better health outcomes. Here we are 25 years later, having pioneered an industry. And we're just getting started. We are broadening our vision beyond diabetes to empower people to take control of health. That means personalized, actionable insights aimed at solving important health challenges. To continue what we've started: Improving human health. We are driven by thousands of ambitious, passionate people worldwide who are willing to fight like warriors to earn the trust of our customers by listening, serving with integrity, thinking big, and being dependable. We've already changed millions of lives and we're ready to change millions more. Our future ambition is to become a leading consumer health technology company while continuing to develop solutions for serious health conditions. We'll get there by constantly reinventing unique biosensing-technology experiences. Though we've come a long way from our small company days, our dreams are bigger than ever. The opportunity to improve health on a global scale stands before us. Role Summary: The SVP, Chief Medical Officer (CMO) is Dexcom's senior-most medical leader and the CEO's primary advisor on clinical strategy, medical credibility, and evidence priorities. The CMO is accountable for enterprise medical strategy, clinical evidence generation, HEOR and real-world evidence, and medical governance across Dexcom's portfolio in diabetes and metabolic health. The CMO leads Clinical Affairs and Medical Affairs, with VP-level leaders of each function reporting into the role. The CMO partners closely with Operations & Quality, Regulatory Affairs, Product, Commercial, and Market Access to ensure strong governance, post-market oversight, and consistent, evidence-based medical positioning. Where you come in: Set enterprise medical strategy for Dexcom across diabetes, with strong Type 2 credibility and a clear metabolic health narrative. Own the evidence roadmap and ensure the right mix of clinical studies and real-world evidence supports adoption, guidelines, and growth. Lead HEOR and RWE efforts, producing payer-ready evidence and reimbursement support in tight partnership with Commercial Market Access. Oversee global Medical Affairs including KOL strategy, scientific communications, publications, congress presence, and medical education. Chair medical governance and safety oversight for benefit-risk decisions, post-market clinical surveillance input, and medically grounded field actions in partnership with Operations, Quality, and Regulatory. Guide portfolio expansion and access pathways including pharmacy and consumer routes where applicable, with evidence-based positioning and appropriate-use guardrails. Enable global growth by ensuring medical strategy, evidence, and narratives translate across regions, health systems, and reimbursement environments. What success looks like: A CEO-aligned medical strategy that is clearly anchored in diabetes, with strong Type 2 credibility and a coherent metabolic health narrative. A funded evidence roadmap that strengthens differentiation, supports guidelines and access, and enables expansion in Type 2 segments. A high-performing HEOR and RWE partnership with Market Access that accelerates coverage expansion and improves credibility of payer narratives. Strong medical governance and post-market readiness with clear, timely cross-functional decision-making. Increased external credibility through stronger KOL impact, consistent high-trust communications, and higher-quality scientific output. Required Qualifications: MD required; board certification strongly preferred. Significant executive leadership in diabetes care or related therapeutic areas, including meaningful exposure to Type 2 diabetes populations and care pathways. 15+ years progressive leadership in Clinical Affairs and/or Medical Affairs within regulated medtech, digital health-enabled devices, or closely related environments. Demonstrated success building integrated evidence strategies including real-world evidence and HEOR, with examples of influencing adoption, access, and standard-of-care narratives. Executive presence and ability to partner effectively with CEO and ELT and cross-functional leaders across Market Access, Operations & Quality, Regulatory, Product, and Commercial in a publicly traded environment. Preferred Experience: Metabolic health experience beyond diabetes, including consumer engagement and behavior change programs. Health and wellness exposure, particularly if paired with strong medical governance and appropriate-use discipline. Global medical affairs experience supporting international access expansion. Please note: The information contained herein is not intended to be

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at dexcom? Share your experience